Edition:
United Kingdom

Celyad SA (CYAD.BR)

CYAD.BR on Brussels Stock Exchange

18.25EUR
14 Dec 2018
Change (% chg)

€-0.23 (-1.24%)
Prev Close
€18.48
Open
€18.21
Day's High
€19.06
Day's Low
€17.63
Volume
41,881
Avg. Vol
31,463
52-wk High
€39.94
52-wk Low
€17.63

Chart for

About

Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury. The Company's product, C-Cure,... (more)

Overall

Beta: 1.65
Market Cap(Mil.): €493.66
Shares Outstanding(Mil.): 9.52
Dividend: --
Yield (%): --

Financials

  CYAD.BR Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -2.24 -- --
ROI: -17.72 9.01 14.96
ROE: -24.26 10.15 16.52

Earnings vs. Estimates